Prudential Financial’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,140
| Closed | -$90.6K | – | 2511 |
|
|
2025
Q1 | $90.6K | Buy |
+10,140
| New | +$90.6K | ﹤0.01% | 2138 |
|
|
2024
Q4 | – | Sell |
-57,240
| Closed | -$461K | – | 2684 |
|
|
2024
Q3 | $461K | Buy |
+57,240
| New | +$461K | ﹤0.01% | 2250 |
|
|
2023
Q4 | – | Sell |
-16,505
| Closed | -$142K | – | 2715 |
|
|
2023
Q3 | $142K | Sell |
16,505
-4,680
| -22% | -$40.4K | ﹤0.01% | 2424 |
|
|
2023
Q2 | $219K | Buy |
21,185
+5,400
| +34% | +$55.9K | ﹤0.01% | 2412 |
|
|
2023
Q1 | $171K | Buy |
+15,785
| New | +$171K | ﹤0.01% | 2419 |
|
|
2019
Q1 | – | Sell |
-9,270
| Closed | -$237K | – | 2467 |
|
|
2018
Q4 | $237K | Sell |
9,270
-40
| -0.4% | -$1.02K | ﹤0.01% | 2196 |
|
|
2018
Q3 | $304K | Sell |
9,310
-140
| -1% | -$4.57K | ﹤0.01% | 2195 |
|
|
2018
Q2 | $214K | Buy |
+9,450
| New | +$214K | ﹤0.01% | 2328 |
|